Pivotal Point of View – July 2025

For allocators evaluating hedge fund performance, context matters.

Pivotal Point In Time:

PivotalPath’s main strategy indices experienced a clean sweep of positive performance in June, as equity markets impressed and ongoing macro dispersion provided opportunities in rates, FX and commodities.

  • June largely continued May’s renewed optimism. PivotalPath saw equity specialists rotate from fear-driven trades to more fundamentals-focused positioning, bolstered by mostly stable economic data and a range of strong corporate earnings.
    • This approach drove PivotalPath Equity Sector Index returns of 3.1% in June, making for a YTD of 1.6%. After a volatile start to the year, hedge fund equity strategies returned 7% in Q2.
    • The PivotalPath Composite Index was up 1.8% across the month, making for a YTD of 3.8%.
  • This sector-wide upswing in performance saw hedge funds ratcheting up risk appetites, with net exposures ticking higher.
  • The ‘shape’ of the risk taking also evolved, with funds leaning harder into growth and momentum (until a momentum unwind on the 1 July!), selectively rotating into quality cyclicals, and trimming short books in sectors previously deemed vulnerable.
    • ‘Trimming’ is the operative word, as managers spoken to by PivotalPath showed little appetite to cover shorts in a significant way, despite a market rebound from early April lows. Confidence has returned, but funds remain cautious about the “volatility to come”.
  • Leverage remained near year-to-date highs, and gross exposures also climbed, though most managers have stayed disciplined, deploying more capital into idiosyncratic trades rather than chasing beta.
    • This has helped dispersion pick up, particularly in tech and biotech, where single-name opportunities have begun to outperform broad index bets.

Sign up to access current and future PPOVs

Already a subscriber? Log In.

View this month’s PPOV

To access this month’s and future PPOVs please provide the following information.

    Interested in actionable hedge fund data 
and industry–leading research?

    We provide transparency for Allocators.

    Get Started